Pfizer CR`s EBITDA Margin reached 4.36 % in 2017. This is 18.2 % more than in the previous year.
Buy EBITDA Margin data for Pfizer Czech Republic.
$19.99Buy all data for Pfizer Czech Republic.
Buy annual subscriptions for all our products.
| Company | Unit | 2000 | 2001 | 2002 | 2003 | 2004 | 2005 | 2006 | 2007 | 2008 | 2009 | 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 |
| Amgen Czech Republic | % | ... | ... | ... | ... | ... | 13.8 | 8.95 | 8.79 | 8.55 | 7.66 | ||||||||
| Bayer Czech Republic | % | ... | ... | ... | 5.01 | 3.46 | 3.94 | 3.53 | 3.93 | ||||||||||
| GlaxoSmithKline Czech Republic | % | ... | ... | ... | 5.33 | 4.08 | 3.34 | 2.87 | 3.17 | ||||||||||
| Merck Czech Republic | % | ... | ... | 4.14 | 4.77 | 2.85 | 2.98 | 5.18 | |||||||||||
| Novartis Czech Republic | % | 1.56 | 1.78 | 1.77 | 2.41 | 2.42 | |||||||||||||
| Pfizer Czech Republic | % | ... | ... | 4.64 | 2.13 | 3.20 | 3.48 | 3.54 | |||||||||||
| Roche Czech Republic | % | ... | ... | ... | 4.14 | 4.20 | 6.66 | 6.07 | 3.84 | ... | |||||||||
| Sanofi-Aventis Czech Republic | % | ... | ... | ... | ... | 1.29 | 1.12 | 1.51 | 0.278 | 1.43 | |||||||||
| Servier Czech Republic | % | ... | ... | ... | ... | ... | ... | ... | ... | ... | ... | ... | ... | 5.76 | 5.82 | 4.72 | 3.61 | ||
| Walmark | % | ... | ... | ... | 15.9 | 6.95 | 6.52 | 9.38 | -19.6 |
Helgi Library 
